Adenocarcinoma, as compared with squamous cell carcinoma, showed increased resting CD4 T cells and resting mast cells, both associated with longer survival, while having lower proportions of M2 macrophages and follicular helper T cells, associated with worse survival. Here, CD4 is linked to adenocarcinoma.